Azenta (AZTA) Cash from Financing Activities (2010 - 2026)
Azenta's (AZTA) quarterly Cash from Financing Activities came in at -$1.7 million in Q1 2026, up 67.95% year-on-year from -$983642.3 in Q1 2025, and up 37.23% on a QoQ basis from -$2.6 million in Q4 2025.
Azenta (AZTA) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Azenta (AZTA) has 17 years of Cash from Financing Activities data on file, last reported at -$1.7 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 67.95% year-over-year to -$1.7 million in Q1 2026; TTM through Mar 2026 was -$9.6 million, a 98.02% increase from a year earlier, with the FY2025 full-year figure at -$9.6 million, up 98.55% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$1.7 million, up from -$2.6 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for AZTA reached as high as $1.8 million in Q3 2022 and fell as low as -$504.7 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged -$98.1 million across 5 years, with a median of -$30.5 million in 2022.
- Across the five-year window, Cash from Financing Activities jumped 139.28% in 2022 and tumbled 16399.04% in 2023, its largest moves.
- Year by year, Cash from Financing Activities stood at -$504.7 million in 2022, then jumped by 77.58% to -$113.2 million in 2023, then surged by 95.47% to -$5.1 million in 2024, then soared by 48.65% to -$2.6 million in 2025, then soared by 37.23% to -$1.7 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$1.7 million in Q1 2026, -$2.6 million in Q4 2025, and -$128000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Azenta | 1.30 Bn | 1.07 Bn | 125.74 Mn | -1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.65 Mn |
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | -2.63 Mn |
| Dec 31, 2025 | -2.63 Mn |
| Jun 30, 2025 | -128,000.00 |
| Jun 30, 2025 | -128,000.00 |
| Mar 31, 2025 | -5.15 Mn |
| Mar 31, 2025 | -5.15 Mn |
| Dec 31, 2024 | -5.13 Mn |
| Dec 31, 2024 | -5.13 Mn |
| Sep 30, 2024 | -247.55 Mn |
| Sep 30, 2024 | -247.55 Mn |
| Jun 30, 2024 | -226.12 Mn |
| Jun 30, 2024 | -226.12 Mn |
| Mar 31, 2024 | -72.39 Mn |
| Mar 31, 2024 | -72.39 Mn |
| Dec 31, 2023 | -113.15 Mn |
| Dec 31, 2023 | -113.15 Mn |
| Sep 30, 2023 | -165.09 Mn |
| Sep 30, 2023 | -165.09 Mn |